Literature DB >> 25973055

LATS2-mediated YAP1 phosphorylation is involved in HCC tumorigenesis.

Chao Guo1, Xintian Wang1, Lufeng Liang1.   

Abstract

YAP (yes-associated protein) is a transcriptional co-activator that acts downstream of the Hippo signaling pathway and regulates multiple cellular processes, including proliferation and apoptosis. Although YAP plays an important role in various tumors, the underlying mechanism in hepatocellular carcinoma (HCC) tumorigenesis remains unclear. In this study, we observed that the LATS2 was highly expressed in Bel-7402 and HepG2 cell lines, and LATS2 protein level was negatively correlated with YAP1 in HCC cells. And then, we inhibited LATS2 expression by transfecting with siRNA. Western blot and Immunofluorescent staining analysis demonstrated that LATS2 inhibition decreased the dephosphorylation of YAP1 protein and promoted YAP1 nuclear accumulation in HCC cells. Moreover, Immunoprecipitation assay results also indicated that Yap binds directly to TEAD2 and LATS2 inhibition-mediated dephosphorylation increased the YAP1/TEAD2 association, leading to YAP1/TEAD2 transcriptional activation, which in turn upregulated cell invasion in HCC cells. Taken together, our current data indicated a new regulatory mechanism of YAP1 by the LATS2-mediated phosphorylation that was involved in HCC tumorigenesis.

Entities:  

Keywords:  Hepatocellular carcinoma; LATS2; TEAD2; YAP1; phosphorylation

Mesh:

Substances:

Year:  2015        PMID: 25973055      PMCID: PMC4396227     

Source DB:  PubMed          Journal:  Int J Clin Exp Pathol        ISSN: 1936-2625


  43 in total

Review 1.  The Hippo pathway: regulators and regulations.

Authors:  Fa-Xing Yu; Kun-Liang Guan
Journal:  Genes Dev       Date:  2013-02-15       Impact factor: 11.361

2.  YAP accelerates Aβ(25-35)-induced apoptosis through upregulation of Bax expression by interaction with p73.

Authors:  Heng Zhang; Shengnan Wu; Da Xing
Journal:  Apoptosis       Date:  2011-08       Impact factor: 4.677

3.  Control of the hippo pathway by Set7-dependent methylation of Yap.

Authors:  Menno J Oudhoff; Spencer A Freeman; Amber L Couzens; Frann Antignano; Ekaterina Kuznetsova; Paul H Min; Jeffrey P Northrop; Bernhard Lehnertz; Dalia Barsyte-Lovejoy; Masoud Vedadi; Cheryl H Arrowsmith; Hiroshi Nishina; Michael R Gold; Fabio M V Rossi; Anne-Claude Gingras; Colby Zaph
Journal:  Dev Cell       Date:  2013-07-11       Impact factor: 12.270

4.  Structural and functional insights into the TEAD-YAP complex in the Hippo signaling pathway.

Authors:  Liming Chen; Portia Gloria Loh; Haiwei Song
Journal:  Protein Cell       Date:  2011-01-08       Impact factor: 14.870

5.  LATS2 is a tumor suppressor gene of malignant mesothelioma.

Authors:  Hideki Murakami; Tetsuya Mizuno; Tetsuo Taniguchi; Makiko Fujii; Futoshi Ishiguro; Takayuki Fukui; Shinya Akatsuka; Yoshitsugu Horio; Toyoaki Hida; Yutaka Kondo; Shinya Toyokuni; Hirotaka Osada; Yoshitaka Sekido
Journal:  Cancer Res       Date:  2011-01-18       Impact factor: 12.701

6.  The RhoA pathway mediates MMP-2 and MMP-9-independent invasive behavior in a triple-negative breast cancer cell line.

Authors:  Katerina D Fagan-Solis; Sallie Smith Schneider; Brian T Pentecost; Brook A Bentley; Christopher N Otis; John F Gierthy; Kathleen F Arcaro
Journal:  J Cell Biochem       Date:  2013-06       Impact factor: 4.429

7.  LATS2 suppresses oncogenic Wnt signaling by disrupting β-catenin/BCL9 interaction.

Authors:  Jiong Li; Xiaohong Chen; Xiangming Ding; Yingduan Cheng; Bin Zhao; Zhi-Chun Lai; Khalid Al Hezaimi; Razqallah Hakem; Kun-Liang Guan; Cun-Yu Wang
Journal:  Cell Rep       Date:  2013-12-19       Impact factor: 9.423

8.  MicroRNA-181b promotes ovarian cancer cell growth and invasion by targeting LATS2.

Authors:  Ying Xia; Yan Gao
Journal:  Biochem Biophys Res Commun       Date:  2014-04-13       Impact factor: 3.575

9.  YAP/TEAD-mediated transcription controls cellular senescence.

Authors:  Qi Xie; Jing Chen; Han Feng; Shengyi Peng; Ursula Adams; Yujie Bai; Li Huang; Ji Li; Junjian Huang; Songshu Meng; Zengqiang Yuan
Journal:  Cancer Res       Date:  2013-04-10       Impact factor: 12.701

10.  LATS2 is de-methylated and overexpressed in nasopharyngeal carcinoma and predicts poor prognosis.

Authors:  Yan Zhang; Chun-Fang Hu; Jing Chen; Li-Xu Yan; Yi-Xin Zeng; Jian-Yong Shao
Journal:  BMC Cancer       Date:  2010-10-08       Impact factor: 4.430

View more
  20 in total

Review 1.  YAP and the Hippo pathway in pediatric cancer.

Authors:  Atif A Ahmed; Abdalla D Mohamed; Melissa Gener; Weijie Li; Eugenio Taboada
Journal:  Mol Cell Oncol       Date:  2017-02-25

2.  LATS2 Inhibits Malignant Behaviors of Glioma Cells via Inactivating YAP.

Authors:  Yi Shi; Decheng Geng; Yu Zhang; Min Zhao; Yan Wang; Yang Jiang; Rutong Yu; Xiuping Zhou
Journal:  J Mol Neurosci       Date:  2019-02-15       Impact factor: 3.444

3.  The clinical significance and biological function of large tumour suppressor 2 in hepatocellular carcinoma.

Authors:  Rong Liang; Yan Lin; Chun-Ling Yuan; Zhi-Hui Liu; Yong-Qiang Li; Xiao-Ling Luo; Jia-Zhou Ye; Hai-Hong Ye
Journal:  Cell Prolif       Date:  2017-03-01       Impact factor: 6.831

4.  RETRACTED ARTICLE: The novel long non-coding RNA LATS2-AS1-001 inhibits gastric cancer progression by regulating the LATS2/YAP1 signaling pathway via binding to EZH2.

Authors:  Dan Sun; Ying Wang; Huan Wang; Yan Xin
Journal:  Cancer Cell Int       Date:  2020-05-29       Impact factor: 6.429

5.  Long non‑coding RNA ASAP1‑IT1 suppresses ovarian cancer progression by regulating Hippo/YAP signaling.

Authors:  Ke Wang; Yu-Bo Hu; Ye Zhao; Cong Ye
Journal:  Int J Mol Med       Date:  2021-02-12       Impact factor: 4.101

6.  TEAD1/4 exerts oncogenic role and is negatively regulated by miR-4269 in gastric tumorigenesis.

Authors:  Y Zhou; T Huang; J Zhang; C C Wong; B Zhang; Y Dong; F Wu; J H M Tong; W K K Wu; A S L Cheng; J Yu; W Kang; K F To
Journal:  Oncogene       Date:  2017-07-31       Impact factor: 9.867

7.  YAP1 enhances cell proliferation, migration, and invasion of gastric cancer in vitro and in vivo.

Authors:  Dan Sun; Xiaoting Li; Yingjian He; Wenhui Li; Ying Wang; Huan Wang; Shanshan Jiang; Yan Xin
Journal:  Oncotarget       Date:  2016-12-06

8.  Deubiquitinating Enzyme USP9X Suppresses Tumor Growth via LATS Kinase and Core Components of the Hippo Pathway.

Authors:  Aleksandra Toloczko; Fusheng Guo; Hiu-Fung Yuen; Qing Wen; Stephen A Wood; Yan Shan Ong; Pei Yi Chan; Asfa Alli Shaik; Jayantha Gunaratne; Mark J Dunne; Wanjin Hong; Siew Wee Chan
Journal:  Cancer Res       Date:  2017-07-18       Impact factor: 12.701

Review 9.  The TEAD Family and Its Oncogenic Role in Promoting Tumorigenesis.

Authors:  Yuhang Zhou; Tingting Huang; Alfred S L Cheng; Jun Yu; Wei Kang; Ka Fai To
Journal:  Int J Mol Sci       Date:  2016-01-21       Impact factor: 5.923

10.  Long noncoding RNA MLK7-AS1 promotes ovarian cancer cells progression by modulating miR-375/YAP1 axis.

Authors:  Huan Yan; Hong Li; Pengyun Li; Xia Li; Jianjian Lin; Linlin Zhu; Maria A Silva; Xiaofang Wang; Ping Wang; Zhan Zhang
Journal:  J Exp Clin Cancer Res       Date:  2018-09-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.